|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/5377 | (2013.01) | ||
| C07C 59/245 | (2006.01) | ||
| C07C 309/35 | (2013.01) | ||
| C07C 51/41 | (2013.01) | ||
| C07C 59/255 | (2006.01) | ||
| C07C 51/43 | (2013.01) | ||
| C07C 309/35 | (2006.01) | ||
| C07C 53/10 | (2006.01) | ||
| C07C 53/10 | (2013.01) | ||
| C07C 51/41 | (2006.01) | ||
| C07C 59/245 | (2013.01) | ||
| C07C 51/43 | (2006.01) | ||
| C07C 59/255 | (2013.01) | ||
| A61K 31/5377 | (2006.01) | ||
| C07D 471/04 | (2013.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 9/12 | (2018.01) |
| (11) | Number of the document | 3398946 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16881245.1 |
| Date of filing the European patent application | 2016-12-29 | |
| (97) | Date of publication of the European application | 2018-11-07 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2016/112966 |
| Date | 2016-12-29 |
| (87) | Number | WO 2017/114456 |
| Date | 2017-07-06 |
| (30) | Number | Date | Country code |
| 201511016783 | 2015-12-29 | CN |
| (72) |
XIA, Guangxin , CN
XIE, Jianshu , CN
JIA, Guohui , CN
HAN, Jiansheng , CN
UEDA, Naoko , JP
IIJIMA, Toru , JP
|
| (73) |
Shanghai Pharmaceuticals Holding Co., Ltd. ,
No. 92 Zhang Jiang Road
Pudong District, Shanghai 201203,
CN
|
| (54) | SALT OF MORPHOLINE DERIVATIVE AND CRYSTALLINE FORM THEREOF, AS WELL AS PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE OF THE SAME |
| SALT OF MORPHOLINE DERIVATIVE AND CRYSTALLINE FORM THEREOF, AS WELL AS PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE OF THE SAME |